Skip to main content
UniHealth

Doctor search

Oscar Silva, MD

Pathology · Stanford

NPI 1396131140

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
1
1 carrier
Offices
2
Since medical school
11 years
University of California, Geffen School of Medicine, 2015

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

1 plan · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Silva’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A143984 · Current

Licensed to practise in California · since 2016 · expires 2028-03-31 · David Geffen School of Medicine at UCLA.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Pathology - Hematopathology
  • American Board of Pathology - Pathology – Anatomic/Pathology- Clinical

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$57,940

Medicare paid this office $57,940 for 402 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Flow cytometry technique for dna or cell analysis, 16 or more markers218$16,468$74
Special stained specimen slides to examine tissue, each additional procedure72$7,581$25
Pathology examination of tissue using a microscope, intermediate complexity124$6,690$33
Bone marrow, smear interpretation110$4,979$43
Flow cytometry technique for dna or cell analysis, 9 to 15 markers76$4,853$55
See all 14 services
Every Original Medicare service billed
Flow cytometry technique for dna or cell analysis, 16 or more markers218$16,468$74
Special stained specimen slides to examine tissue, each additional procedure72$7,581$25
Pathology examination of tissue using a microscope, intermediate complexity124$6,690$33
Bone marrow, smear interpretation110$4,979$43
Flow cytometry technique for dna or cell analysis, 9 to 15 markers76$4,853$55
Special stained specimen slides to examine tissue, initial procedure92$3,053$31
Surgical pathology consultation and report on referred slides prepared elsewhere34$2,390$70
Genetic sequencing localization, initial procedure49$2,001$38
Microscopic genetic analysis of tumor, manual38$1,972$37
Genetic sequencing localization, each additional procedure41$1,515$30
Preparation of tissue for examination by removing any calcium present108$1,247$11
Cell examination of specimen, concentration technique40$850$20
Special stained specimen slides to examine tissue including interpretation and report53$721$11
Blood smear interpretation by physician with written report18$388$22

Who their Medicare patients are

402 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 13% · Women 48% · Also on Medicaid 19% · Health risk score 2.13. Above the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 73% · Coronary heart disease 32% · Chronic kidney disease 31% · Diabetes 28% · Atrial fibrillation 26% · Heart failure 22% · Cancer 21% · Depression 20% · COPD 15% · Dementia 11% · Stroke 9%.

The office billed $600,967, Medicare allowed $73,474 and paid $57,940; for 1,521 services of 27 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244021,521742.13$600,967$57,940
20233691,403742.16$483,864$55,935
20222841,177731.95$354,496$44,504
20213051,291722.34$346,302$49,742
2020119438721.92$120,809$18,115

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 14 services

Original Medicare services billed in 2023
Flow cytometry technique for dna or cell analysis, 16 or more markers204$16,764$77
Pathology examination of tissue using a microscope, intermediate complexity144$6,823$35
Bone marrow, smear interpretation142$6,730$45
Flow cytometry technique for dna or cell analysis, 9 to 15 markers89$6,090$57
Special stained specimen slides to examine tissue, each additional procedure50$4,835$26
Surgical pathology consultation and report on referred slides prepared elsewhere31$2,493$78
Special stained specimen slides to examine tissue, initial procedure66$2,373$33
Microscopic genetic analysis of tumor, manual42$2,061$39
Preparation of tissue for examination by removing any calcium present137$1,667$11
Genetic sequencing localization, initial procedure39$1,647$40
Genetic sequencing localization, each additional procedure32$1,142$32
Special stained specimen slides to examine tissue including interpretation and report61$822$11
Cell examination of specimen, concentration technique33$753$20
Blood smear interpretation by physician with written report25$625$22

2022: 13 services

Original Medicare services billed in 2022
Flow cytometry technique for dna or cell analysis, 16 or more markers147$11,500$75
Special stained specimen slides to examine tissue, each additional procedure51$5,950$26
Bone marrow, smear interpretation106$4,668$43
Pathology examination of tissue using a microscope, intermediate complexity118$4,601$34
Surgical pathology consultation and report on referred slides prepared elsewhere43$3,224$75
Microscopic genetic analysis of tumor, manual55$2,902$38
Flow cytometry technique for dna or cell analysis, 9 to 15 markers38$2,347$55
Special stained specimen slides to examine tissue, initial procedure67$2,309$32
Preparation of tissue for examination by removing any calcium present110$1,288$11
Genetic sequencing localization, initial procedure32$1,264$39
Special stained specimen slides to examine tissue including interpretation and report51$841$11
Genetic sequencing localization, each additional procedure24$801$31
Cell examination of specimen, concentration technique31$605$20

2021: 14 services

Original Medicare services billed in 2021
Flow cytometry technique for dna or cell analysis, 16 or more markers137$10,849$75
Special stained specimen slides to examine tissue, each additional procedure57$6,616$27
Bone marrow, smear interpretation112$5,603$46
Pathology examination of tissue using a microscope, intermediate complexity123$4,888$35
Surgical pathology consultation and report on referred slides prepared elsewhere45$3,603$78
Flow cytometry technique for dna or cell analysis, 9 to 15 markers49$3,473$58
Microscopic genetic analysis of tumor, manual52$3,289$40
Special stained specimen slides to examine tissue, initial procedure67$2,351$33
Genetic sequencing localization, initial procedure37$1,642$41
Preparation of tissue for examination by removing any calcium present116$1,486$12
Cell examination of specimen, concentration technique57$1,403$21
Genetic sequencing localization, each additional procedure25$1,113$33
Special stained specimen slides to examine tissue including interpretation and report37$589$11
Blood smear interpretation by physician with written report16$348$22

2020: 10 services

Original Medicare services billed in 2020
Flow cytometry technique for dna or cell analysis, 16 or more markers46$3,887$81
Special stained specimen slides to examine tissue, each additional procedure22$2,844$28
Surgical pathology consultation and report on referred slides prepared elsewhere16$1,534$81
Flow cytometry technique for dna or cell analysis, 9 to 15 markers24$1,524$61
Microscopic genetic analysis of tumor, manual17$1,437$41
Bone marrow, smear interpretation30$1,416$46
Pathology examination of tissue using a microscope, intermediate complexity36$1,396$37
Special stained specimen slides to examine tissue, initial procedure28$997$34
Cell examination of specimen, concentration technique21$503$22
Preparation of tissue for examination by removing any calcium present30$384$12

Medicaid work

$9,000 in 2024

Medicaid paid $9,000 for 276 billed services this clinician did in 2024, up to 24 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)65$1,760
Flow cytometry, interpretation; 9 to 15 markers26$1,600
Blood smear, peripheral, interpretation by physician with written report96$1,460
Flow cytometry, interpretation; 16 or more markers28$1,436
Bone marrow, smear interpretation27$1,400
TISSUE EXAM BY PATHOLOGIST34$1,343
Medicaid work by year
2024276624$9,000
2023316732$7,760
2022220518$6,160
202196217$2,322
202018115$412
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)97$2,511
Flow cytometry, interpretation; 16 or more markers29$1,826
Blood smear, peripheral, interpretation by physician with written report105$1,312
Bone marrow, smear interpretation33$1,152
Flow cytometry, interpretation; 9 to 15 markers13$714
TISSUE EXAM BY PATHOLOGIST20$211
DECALCIFICATION PROCEDURE19$35

2022

Largest Medicaid services in 2022
Bone marrow, smear interpretation69$2,499
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)84$1,970
TISSUE EXAM BY PATHOLOGIST27$981
Flow cytometry, interpretation; 16 or more markers12$522
DECALCIFICATION PROCEDURE28$189

2021

Largest Medicaid services in 2021
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)84$1,931
Bone marrow, smear interpretation12$392

2020

Largest Medicaid services in 2020
Cytopathology, concentration technique, smears and interpretation (eg, Saccomanno technique)18$412

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1396131140
Licence
CA A143984California A143984: Current · expires 2028-03-31
Trained
University of California, Geffen School of Medicine, 2015 · 11 years ago
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207ZP0101X (207ZP0101X); Federal specialty code 207ZH0000X (207ZH0000X); Federal specialty code 207ZP0102X (207ZP0102X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2015-04-08
NPI last updated
2024-03-13
NPI record certified
2024-03-13

This is when the NPI record was last certified, not a medical board exam.